Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)
China
· Delayed Price · Currency is CNY 14.06
+0.13 (0.93%)
Apr 30, 2026, 11:54 AM CST
SHE:002907 Revenue
In the year 2025, Chongqing Pharscin Pharmaceutical had annual revenue of 827.14M CNY with 6.75% growth. Chongqing Pharscin Pharmaceutical had revenue of 201.23M in the quarter ending December 31, 2025, with 25.30% growth.
Revenue
827.14M
Revenue Growth
+6.75%
P/S Ratio
7.03
Revenue / Employee
597.65K
Employees
1,384
Market Cap
5.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 827.14M | 52.32M | 6.75% |
| Dec 31, 2024 | 774.82M | 83.28M | 12.04% |
| Dec 31, 2023 | 691.54M | -93.64M | -11.93% |
| Jan 1, 2023 | 785.18M | -60.96M | -7.20% |
| Jan 1, 2022 | 846.14M | -36.33M | -4.12% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanxi Zhendong Pharmaceutical Co.,Ltd | 2.68B |
| ChengDu ShengNuo Biotec | 801.40M |
| Jiangsu Lianhuan Pharmaceutical | 2.71B |
| Luoxin Pharmaceuticals Group Stock | 2.37B |
| Shanghai Kaibao Pharmaceutical CO.,Ltd | 1.15B |
| Jiangsu Jibeier Pharmaceutical | 966.07M |
| HPGC Renmintongtai Pharmaceutical | 10.54B |
| Guizhou Xinbang Pharmaceutical | 5.62B |